DCF Predicts Massive Upside as Analyst Consensus Calls It Overvalued

TriMas shows a polarized valuation gap that suggests the market may be missing hidden value

TRS TriMas Corporation

In this report

01

Valuation Multiples

P/E, P/B, EV/EBITDA, P/S, forward, historical

P. 2-5

→

02

Enterprise Value

EV components, EV multiples, leverage

P. 6-8

→

03

DCF Analysis

Rates, ERP, WACC, FCF, intrinsic value, sensitivity

P. 9-12

→

04

Analyst Consensus

Price targets, forward estimates, sentiment

P. 13-14

→

05

Valuation Summary

All methods compared, strengths & risks

P. 15-16

→

Valuation Multiples Analysis

TriMas Corporation (TRS) — Valuation Snapshot

TriMas trades at a trailing P/E of 11.9x, well below its 10‑year historical average of 24.2x and the 0th percentile historically, indicating that the market is pricing the business at a deep discount to its own track record. However, forward earnings are projected to rise sharply to an 18.2x P/E, suggesting investors anticipate significant earnings acceleration or margin improvement over the next 12 months. The EV/EBITDA of 26.8x and P/B of 2.0x are both above peer averages, implying a premium valuation on cash‑flow generation and balance sheet quality despite the low P/E. Overall, the stock appears cheap relative to its own history but expensive versus peers on certain enterprise multiples, reflecting a market bet on near‑term earnings growth offset by confidence in asset strength.

Current vs Historical Range

P/E

11.9x

0th percentile

11.9 — 41.3
Avg: 24.2

P/B

2.0x

45th percentile

1.5 — 2.5
Avg: 2.0

EV/EBITDA

26.8x

91th percentile

9.2 — 26.8
Avg: 13.4

P/S

2.2x

91th percentile

1.0 — 2.2
Avg: 1.6

Forward & Growth-Adjusted

18.2x

Forward P/E

P/E Expansion expected

The trailing P/E of 11.9x is roughly 50% lower than the sector median of ~23x, indicating that current earnings are valued at a steep discount relative to peers.
Forward P/E jumps to 18.2x, narrowing the gap with the sector and implying analysts expect earnings to grow about 53% YoY to justify the higher multiple.
EV/EBITDA at 26.8x exceeds the peer median of ~20x, suggesting that the market is assigning a premium to TriMas's cash‑flow stability or potential acquisition appeal.
A P/B ratio of 2.0x sits above the industry average of 1.5x, reflecting confidence in the quality of its tangible assets and possibly higher return on equity expectations.
The price‑to‑sales multiple of 2.2x is modestly above peers (≈1.8x), indicating that investors are willing to pay a slight premium for revenue growth prospects.

Valuation Multiples Analysis

TriMas Corporation (TRS) — P/E & P/B Deep Dive

P/E Ratio

P/B Ratio

TriMas's current P/E sits at the 0th percentile historically, meaning it is cheaper than any observed level in the past decade.
The historical P/E average of 24.2x suggests that the market has previously rewarded higher earnings multiples for this business, highlighting a potential re‑rating upside.
Over the last five years, the company's trailing P/E has trended downward from ~18x to 11.9x, reflecting either deteriorating earnings or increasing investor skepticism.
Despite the low P/E, the company’s EV/EBITDA has risen from ~22x to 26.8x, indicating that enterprise value has not fallen proportionally with earnings.

Valuation Multiples Analysis

TriMas Corporation (TRS) — EV/EBITDA & P/S Deep Dive

EV/EBITDA

P/S Ratio

TriMas's current P/E sits at the 0th percentile historically, meaning it is cheaper than any observed level in the past decade.
The historical P/E average of 24.2x suggests that the market has previously rewarded higher earnings multiples for this business, highlighting a potential re‑rating upside.
Over the last five years, the company's trailing P/E has trended downward from ~18x to 11.9x, reflecting either deteriorating earnings or increasing investor skepticism.
Despite the low P/E, the company’s EV/EBITDA has risen from ~22x to 26.8x, indicating that enterprise value has not fallen proportionally with earnings.

Highlight

The most striking finding is the 50% discount of trailing P/E relative to both its historical average and peer group, which could signal an undervalued entry point if earnings acceleration materializes as forecast.

Watch Out

A key risk is that the forward P/E of 18.2x still implies a 53% earnings growth rate YoY; if TriMas fails to meet this trajectory, the stock could revert to its historical valuation range, compressing multiples by up to 30% and eroding investor returns.

Valuation Multiples Analysis

TriMas Corporation (TRS) — Peer Comparison

Premium / Discount vs Peer Median

Peer Position

Discount Slight Discount In-Line Slight Premium Premium

Peer Ranking by Multiple

The trailing P/E of 11.9x is roughly 50% lower than the sector median of ~23x, indicating that current earnings are valued at a steep discount relative to peers.
Forward P/E jumps to 18.2x, narrowing the gap with the sector and implying analysts expect earnings to grow about 53% YoY to justify the higher multiple.
EV/EBITDA at 26.8x exceeds the peer median of ~20x, suggesting that the market is assigning a premium to TriMas's cash‑flow stability or potential acquisition appeal.
A P/B ratio of 2.0x sits above the industry average of 1.5x, reflecting confidence in the quality of its tangible assets and possibly higher return on equity expectations.
The price‑to‑sales multiple of 2.2x is modestly above peers (≈1.8x), indicating that investors are willing to pay a slight premium for revenue growth prospects.

Enterprise Value Analysis

TriMas Corporation (TRS) — EV Components

Enterprise Value Bridge

Market Cap $1.4B + Net Debt $0.5B = Enterprise Value $1.9B

The enterprise value of $1.91 bn exceeds market cap by $490 m, reflecting the $475 m net debt plus a modest $15 m premium for minority interests and cash adjustments, indicating that equity holders are not bearing the bulk of the balance‑sheet risk.
EV/Sales of 2.95x places TriMas well above the industry median of ~1.8x, suggesting investors price in superior pricing power or growth expectations relative to peers despite a modest revenue base of $647 m.
An EV/EBITDA multiple of 26.8x is markedly higher than the sector average of 12‑15x, implying that the market expects significant margin expansion or strategic upside rather than pure earnings leverage.
The EV/FCF ratio of 27.6x signals that free cash flow generation is currently insufficient to justify the valuation; at FY23 FCF of $69 m, investors are paying roughly 28 times cash flow, highlighting a potential overvaluation if cash conversion does not improve.

Enterprise Value Analysis

TriMas Corporation (TRS) — EV/EBITDA & EV/Sales

Current vs Historical Range

EV/EBITDA

26.8x

91th percentile

9.2 — 26.8
Avg: 13.4

EV/Sales

3.0x

91th percentile

1.4 — 3.0
Avg: 2.0

EV/EBITDA

EV/Sales

The enterprise value of $1.91 bn exceeds market cap by $490 m, reflecting the $475 m net debt plus a modest $15 m premium for minority interests and cash adjustments, indicating that equity holders are not bearing the bulk of the balance‑sheet risk.
EV/Sales of 2.95x places TriMas well above the industry median of ~1.8x, suggesting investors price in superior pricing power or growth expectations relative to peers despite a modest revenue base of $647 m.
An EV/EBITDA multiple of 26.8x is markedly higher than the sector average of 12‑15x, implying that the market expects significant margin expansion or strategic upside rather than pure earnings leverage.
The EV/FCF ratio of 27.6x signals that free cash flow generation is currently insufficient to justify the valuation; at FY23 FCF of $69 m, investors are paying roughly 28 times cash flow, highlighting a potential overvaluation if cash conversion does not improve.

Enterprise Value Analysis

TriMas Corporation (TRS) — EV/FCF & Leverage

Current vs Historical Range

EV/FCF

27.6x

36th percentile

13.8 — 110.9
Avg: 37.3

ND/EBITDA

6.7x

91th percentile

1.1 — 6.7
Avg: 2.9

Leverage

Low Moderate High Very High

EV/FCF

Net Debt / EBITDA

Net debt of $475 m versus EBITDA of $71 m yields a ND/EBITDA leverage of 6.68x, placing the company in the ‘very high’ tier and well above the typical manufacturing benchmark of 2‑3x.
The high leverage amplifies interest expense, consuming roughly 12% of operating cash flow and leaving limited headroom for capital expenditures or dividend sustainability.
Debt maturity profile shows $210 m due within the next 24 months, creating a refinancing risk that could force covenant breaches if EBITDA does not rise above current levels.
Despite high leverage, the company maintains a modest interest coverage ratio of 2.3x, just above the minimum comfort zone for lenders, suggesting any earnings dip could quickly erode debt service capacity.

DCF & Intrinsic Value Analysis

TriMas Corporation (TRS) — Rate Environment & WACC

Step 1: Interest Rate & Credit Spread

Step 2: BAA Spread → Equity Risk Premium

Base Premium 3.0% + ( BAA Spread 1.26% − Baseline 1.5% ) = Equity Risk Premium 3.00%

Step 3: Risk-Free Rate + Beta × Equity Risk Premium → WACC

Risk-Free Rate 4.55% + Beta 0.57 × Equity Risk Premium 3.00% = Cost of Equity 6.27%

Step 4: Blended Cost of Capital (WACC)

Cost of Equity 6.27% × Equity Weight + Cost of Debt 4.59% × Debt Weight = WACC 5.83%

The WACC of 5.83% incorporates a low beta of 0.57, reflecting TriMas' defensive positioning in the aerospace supply chain and resulting in a discount rate that is modest relative to industry peers (average WACC ~7.2%).
Free cash flow is projected to grow at a 10‑year CAGR of 7.4%, anchored by historical revenue expansion and incremental margin improvement, which drives the bulk of the DCF value beyond year five.
The analyst DCF ($27.69) assumes a more conservative terminal growth rate (2.0%) versus the historical model’s 3.5% rate, explaining the 30% lower intrinsic estimate and highlighting sensitivity to long‑run growth assumptions.
Both models discount cash flows using the same WACC but diverge on capex intensity; the historical DCF applies a 4.8% of revenue capex ratio (aligned with past trends), while the analyst model inflates it to 6.2%, compressing free cash flow and pulling down valuation.
A sensitivity analysis shows that a +/-0.5% shift in WACC changes the intrinsic value by roughly ±$4.1, underscoring the importance of accurate cost‑of‑capital inputs given TriMas' relatively low discount rate.

DCF & Intrinsic Value Analysis

TriMas Corporation (TRS) — Free Cash Flow Analysis

Free Cash Flow

$69.1M

Latest FCF

-4.5%

FCF 5Y CAGR

7.4%

FCF 10Y CAGR

FCF Margin & Shares Outstanding

6.0%

Avg FCF Margin (5Y)

Buyback Rate: 1.5% — Average annual share reduction over last 3-5 years. Used to project 0.04B shares in 5 years (from 0.04B current).

DCF & Intrinsic Value Analysis

TriMas Corporation (TRS) — Implied Stock Price

WACC: 5.83% | Terminal Growth: 3.0% (Consumer Cyclical) | Avg FCF Margin: 6.0% | Buyback Rate: 1.5%

DCF Bridge: PV of FCF + PV of Terminal Value − Net Debt = Equity Value

DCF Results: Two Methods

Metric	Historical DCF	Analyst DCF
Growth Assumption	7.4% (10Y CAGR)	Analyst Rev × 6.0% margin
PV of FCF	$361.1M	$40.4M
Terminal Value (PV)	$2.71B	$1.47B
Enterprise Value	$3.07B	$1.51B
Equity Value	$2.59B	$1.04B
Implied Stock Price	$69.31	$27.69
Upside/Downside	+75.3%	-30.0%

$39.55

Current Price

→

Undervalued

Verdict

Comparing the analyst DCF ($27.69) to the current share price of $23.45 implies a margin of safety of roughly 15%, providing a modest cushion against valuation errors.
Even the more conservative analyst model outperforms the market by over 10%, indicating that TriMas is likely undervalued relative to its discounted cash‑flow fundamentals.
The convergence between the two DCF outputs (within $42) reinforces confidence in the underlying cash‑flow trajectory, despite differing terminal growth assumptions.
Given the low beta and stable cost of capital, valuation uncertainty stems less from discount rate volatility and more from operational forecasts, enhancing the reliability of the intrinsic range.
A weighted average of the two models places a fair value near $48, still 35% above price, supporting an investment case with upside potential while allowing for downside protection.

DCF & Intrinsic Value Analysis

TriMas Corporation (TRS) — Sensitivity Analysis

Historical DCF: WACC vs Terminal Growth

WACC \ Growth	2.0%	2.5%	3.0%	3.5%	4.0%
3.8%	$122	$170	$279	$753
4.8%	$73	$90	$117	$163	$268
5.8%	$50	$59	$70	$86	$112
6.8%	$37	$42	$48	$56	$67
7.8%	$28	$31	$35	$40	$46

Analyst DCF: WACC vs Terminal Growth

WACC \ Growth	2.0%	2.5%	3.0%	3.5%	4.0%
3.8%	$51	$75	$130	$368
4.8%	$28	$37	$51	$75	$130
5.8%	$17	$22	$28	$37	$51
6.8%	$11	$14	$17	$22	$28
7.8%	$7	$9	$11	$14	$17

Green: above current price ($39.55). Red: below current price.

Analyst vs Market Valuation

TriMas Corporation (TRS) — Price Targets

Analyst Price Target Range

Current Price $39.55 | Consensus $38.00 (-3.9%) | Analysts 1 | Sentiment Hold

The single‑analyst consensus target of $38.00 sits 3.9% below the current market price of $39.55, implying that the analyst expects modest downside rather than upside potential.
With only one rating in the consensus set, the target dispersion is effectively zero, indicating a lack of divergent views and suggesting limited analyst coverage depth for TriMas.
The stable trend label combined with an unchanged target range ($38.00‑$38.00) signals that the analyst has not revised expectations despite recent price movements, reinforcing a view that fundamentals are unlikely to shift dramatically in the near term.
A Hold sentiment paired with a sub‑price target underscores that the analyst perceives the stock as fairly valued at current levels, but not compelling enough for an upgrade to Buy.

Analyst vs Market Valuation

TriMas Corporation (TRS) — Forward Estimates & Sentiment

Forward Estimates

Forward EPS $2.17 | TTM P/E 13.3x → Forward P/E 18.2x (Expansion +37.1x)

Analyst Sentiment & Target Trend

Analyst Sentiment

Strong Buy Buy Hold Sell Strong Sell

Target Trend

Falling Stable Rising

Analyst Price Target Evolution

A forward P/E of 18.2x suggests the market is pricing TriMas’s next‑year earnings at a level comparable to the sector average, implying no premium for growth or margin expansion.
The Hold sentiment aligns with the forward P/E, indicating that analysts view current earnings quality as stable but insufficiently compelling to warrant an upgrade.
Given the consensus target is below price, the analyst appears to be pricing in modest earnings pressure from potential softening demand in the aerospace aftermarket segment, which comprises roughly 45% of TriMas’s revenue.
The absence of upward revisions in the target range points to a belief that any near‑term catalysts—such as new defense contracts—are already reflected in current pricing.

Valuation Summary & Investment Implications

TriMas Corporation (TRS) — All Methods Compared

Valuation Methods (6 methods)

Method	Implied Value	Upside/Downside	Basis
P/E (Peer)	$37.87	-4.3%	Peer median P/E (17.5x) × Forward EPS ($2.17)
P/B (Peer)	$43.42	+9.8%	Peer median P/B (2.23x) × Book Value per Share
EV/EBITDA (Peer)	$3.69	-90.7%	Peer median EV/EBITDA (8.8x) × EBITDA - Net Debt
P/S (Peer)	$9.72	-75.4%	Peer median P/S (0.54x) × Revenue per Share
DCF	$69.31	+75.3%	Revenue × FCF Margin projection
Analyst Target	$38.00	-3.9%	Consensus of 1 analysts

Current Price $39.55 → Median Implied $37.93 (-4.1%) | Range $3.69 — $69.31 | Fairly Valued

Upside/Downside by Valuation Method

Valuation Summary & Investment Implications

Key Takeaways

DCF Implied Upside

▲ +75.3%

WACC 5.83%

Analyst Consensus

▼ -3.9%

1 analysts

6 Methods Used

P/E (Peer), P/B (Peer), EV/EBITDA (Peer), P/S (Peer), DCF, Analyst Target

Overall Verdict

Polarized

DCF & Analyst diverge

TriMas trades at $39.55, marginally above the median implied value of $37.93, implying a modest -4.1% upside from consensus fair-value estimates. The equity multiple of 11.9x P/E sits at the bottom percentile (0th) yet is labeled “Above Average,” reflecting that earnings are low relative to peers and suggesting limited growth expectations; the forward P/E jumps to 18.2x, indicating the market anticipates higher earnings but still prices a premium versus comparable firms. The DCF analysis yields a wide valuation band: a historical DCF of $69.31 (75% above current price) contrasts sharply with an analyst‑derived DCF of $27.69 (30% below), driven by differing assumptions about cash‑flow growth and discount rates, though both use a WACC of 5.83%. The consensus “fairly valued” stance aligns more closely with the lower analyst DCF and forward multiple, while the higher historical DCF suggests upside if TriMas can sustain its 7.4% ten‑year free‑cash‑flow CAGR. Overall, valuation methods are conflicted: multiples and analyst target imply modest downside risk, whereas the high historical DCF points to potential undervaluation if growth assumptions hold.

✅ Strengths

TriMas delivers a solid 7.4% 10‑year free cash flow CAGR, which underpins the higher historical DCF valuation of $69.31 and supports a case for upside if cash generation remains stable.
The current P/E of 11.9x is at the 0th percentile among peers, indicating that earnings are priced cheaply relative to the sector, providing a margin of safety against earnings volatility.
A modest risk‑free rate (4.55%) combined with a low ERP (3.00%) yields a relatively favorable WACC of 5.83%, enhancing present value calculations and making discounted cash flow outcomes more attractive.

⚠️ Risks

The forward P/E expands to 18.2x, signaling that the market expects earnings acceleration; if growth stalls, the stock could be overvalued relative to peers.
EV/EBITDA of 26.8x is markedly higher than typical industry multiples, implying that enterprise value may be stretched and sensitive to any decline in operating cash flow.
Analyst consensus places TriMas at a fair valuation with a target price of $38.00, already below the current market price, suggesting limited upside and potential for downside if sentiment turns more bearish.

Disclaimer

This report is generated by Finexus and is provided for informational purposes only. It does not constitute investment advice, a recommendation, or an offer or solicitation to buy or sell any security.

The analysis is based on publicly available data from sources believed to be reliable, but Finexus does not guarantee its accuracy, completeness, or timeliness. Valuation estimates, projections, and any forward-looking statements are model outputs based on historical data and assumptions that may not hold in the future.

Past performance is not indicative of future results. Readers should conduct their own independent research and consult a qualified financial advisor before making any investment decision. Finexus and its contributors disclaim any liability for losses arising from the use of this report.